All Articles

Johnson & Johnson's TRUFILL n-BCA gains FDA approval for chronic subdural hematoma, offering a minimally invasive option to curb high rates of recurrence.

Dr. Philip Golinsky’s alumni award from Life University marks a milestone for RxWellness and the growing trend of integrated, non-surgical patient care.

A new alliance led by engineering giant AtkinsRéalis will deliver the Midlands Rail Hub, a project promising vast economic growth and 300 extra trains daily.

Revelstoke Mountain Resort unveils new luxury homes, fueling its transformation into a year-round hub amid a local housing crunch and soaring demand.

Vancouver-based TRUBAR agrees to a C$201M buyout by Turkish food conglomerate ETİ Gıda, marking a major move in the booming plant-based snack market.

Asia Pacific Wire & Cable is raising $33.9M via a rights offer to fund its US expansion. Shareholders must now weigh participation against dilution risk.

A breakthrough genetic test helps prostate cancer patients avoid severe side effects from radiation while saving the healthcare system millions of dollars.

With trial data showing an average 23% body weight loss, Novo Nordisk's new combination drug CagriSema could usher in a powerful new era for medicine.

Pending home sales fell nearly 6% as high mortgage rates and economic jitters sideline both buyers and sellers, creating a deeply uneven national market.

The appointment of Mars, Inc. veteran Valerie Mars to PureCycle's board signals a major validation for the advanced plastic recycling firm's technology.

With a key drill target identified at its Rio Tinto-partnered project in Montana, the junior explorer is poised for a pivotal year in the hunt for copper.

IIM Udaipur is the first IIM to offer a two-week campus immersion, giving MBA aspirants a unique trial run of B-school life before they commit.

Pharma giant GSK partners with biotech CAMP4, leveraging novel RNA-boosting tech to develop new therapies for neurodegenerative and kidney diseases.

Struggling Inno Holdings rolls the dice with a massive reverse stock split to avoid delisting, but grim financials and a brutal market reaction raise alarms.

After a challenging year marked by a mine fire and merger pains, Core Natural Resources is back online, signaling a major financial turnaround for 2026.

A landmark partnership and new support programs show how a Florida company is weaving community outreach into its core business strategy to tackle critical needs.

An eight-figure deal for Redwire's docking systems is set to equip The Exploration Company's Nyx capsule, marking a key step for European space autonomy.

A new FDA approval for an EGFR-mutated lung cancer therapy cuts treatment from hours to minutes, offering new hope and convenience for thousands of patients.

With a massive potential loan, the U.S. government is backing a plan to mine in Alaska and manufacture in Ohio, aiming to end its reliance on foreign graphite.

The neuro-focused biotech just acquired a late-stage cancer drug, securing massive funding. Is this a brilliant diversification or a high-stakes gamble?